Amebiasis (Entamoeba invadens Infection)

Amebiasis caused by Entamoeba invadens is a significant protozoal disease affecting various reptile species, particularly snakes, lizards, and chelonians. The disease is characterized by necrotizing enteritis, hepatic abscessation, and systemic dissemination, leading to high morbidity and mortality, especially in captive collections. Entamoeba invadens is an anaerobic, cyst-forming amoeba that primarily inhabits the large intestine of infected hosts. In susceptible species, trophozoites invade the intestinal mucosa, causing ulcerative lesions and secondary bacterial infections. The disease is of major concern in herpetoculture due to its rapid spread and severe clinical outcomes. Early diagnosis and aggressive treatment are essential for successful management.

The primary causative agent is the protozoan parasite Entamoeba invadens, a member of the phylum Amoebozoa, class Archamoebea, order Entamoebida, family Entamoebidae. The life cycle includes an infective cyst stage and a replicative trophozoite stage. Cysts are resistant to environmental stressors and are shed in feces, serving as the primary source of transmission. Trophozoites are motile, phagocytic cells that invade the intestinal epithelium and can disseminate via the portal circulation to the liver and other organs. The parasite produces cysteine proteases and amoebapores that facilitate tissue invasion and lysis. Secondary bacterial infections, particularly with Clostridium spp. and coliforms, often complicate the disease. Environmental factors such as high humidity, inadequate sanitation, and overcrowding contribute to the persistence and spread of cysts.

Entamoeba invadens affects a wide range of reptiles, with snakes (especially colubrids, boids, and vipers) being highly susceptible. Among lizards, iguanas, chameleons, and agamids are commonly affected, while chelonians (tortoises and turtles) are generally more resistant but can serve as asymptomatic carriers. The disease is more prevalent in captive collections than in wild populations due to high stocking densities and suboptimal hygiene. Young, immunocompromised, or stressed animals are at increased risk. The parasite is distributed worldwide, with higher incidence in tropical and subtropical regions. In captivity, outbreaks are often associated with the introduction of new animals without proper quarantine. The incubation period ranges from a few days to several weeks, depending on the species and parasite load. Fecal-oral transmission is the primary route, with ingestion of cysts from contaminated food, water, or substrate.

The pathophysiology of amebiasis begins with the ingestion of infective cysts, which excyst in the small intestine, releasing trophozoites that migrate to the large intestine. Trophozoites adhere to the colonic mucosa via lectin adhesins and secrete proteolytic enzymes, causing cytolysis and ulceration. The resulting mucosal damage leads to inflammation, hemorrhage, and necrosis. In severe cases, trophozoites penetrate the submucosa and enter the portal circulation, reaching the liver and causing multiple abscesses. Hepatic involvement is characterized by focal necrosis, microabscess formation, and a granulomatous inflammatory response. Dissemination to other organs, such as the lungs, kidneys, and brain, can occur in advanced cases. The host's immune response, particularly cell-mediated immunity, plays a role in limiting the infection, but immunocompromised animals may develop fulminant disease. Dehydration, electrolyte imbalances, and secondary bacterial sepsis contribute to the high mortality.

Intrinsic predisposing factors include species susceptibility (snakes > lizards > chelonians), age (juveniles more susceptible), and immune status (stress, concurrent disease). Anatomical and physiological characteristics, such as the relatively short gastrointestinal tract in snakes, may facilitate rapid invasion. Extrinsic factors include inadequate husbandry: improper temperature gradients (below the species-specific preferred optimal temperature zone), low humidity for tropical species, poor sanitation, overcrowding, and inadequate quarantine protocols. Dietary factors, such as feeding prey items contaminated with cysts or using water sources contaminated with feces, increase exposure. Stress from handling, transport, or recent environmental changes can suppress the immune system and precipitate clinical disease in carrier animals.

Clinical signs vary with the species and severity of infection. In snakes, early signs include anorexia, lethargy, and regurgitation. As the disease progresses, mucoid or bloody diarrhea, dehydration, and weight loss become evident. In severe cases, snakes may exhibit coelomic distension due to hepatomegaly or ascites. Lizards may show similar signs, along with skin discoloration and reduced activity. Chelonians often present with anorexia, lethargy, and diarrhea, but may remain asymptomatic carriers. In all species, neurological signs (e.g., head tilt, incoordination) can occur if the central nervous system is involved. Physical examination may reveal poor body condition, sunken eyes, and a palpable liver mass in cases of hepatic abscessation. Sudden death can occur in peracute cases, especially in highly susceptible species.

Differential diagnoses include other protozoal infections such as cryptosporidiosis (Cryptosporidium spp.), coccidiosis (Eimeria spp., Isospora spp.), and flagellate infections (e.g., Trichomonas spp.). Bacterial enteritis caused by Salmonella spp., Campylobacter spp., or Clostridium spp. should be considered. Viral diseases, including inclusion body disease (IBD) in boid snakes and paramyxovirus infection, can present with similar signs. Gastrointestinal foreign bodies, intussusception, and neoplasia (e.g., lymphoma) may also cause anorexia and diarrhea. Hepatic disease from other causes, such as fatty liver or toxic hepatopathy, should be ruled out. Definitive diagnosis relies on fecal examination for cysts or trophozoites, PCR testing, and histopathology.

The diagnostic approach begins with a thorough history and physical examination, with attention to husbandry practices and recent introductions. Fecal examination is the first-line diagnostic test: fresh fecal samples should be examined microscopically for motile trophozoites (using direct saline smears) and cysts (using iodine-stained smears or flotation techniques). However, cyst shedding can be intermittent, so multiple samples may be needed. Fecal PCR assays are highly sensitive and specific for Entamoeba invadens DNA. If hepatic involvement is suspected, blood work (complete blood count, serum biochemistry) and coelomic ultrasound or radiography are indicated. Ultrasound-guided fine-needle aspiration of hepatic abscesses can be performed for cytology and culture. In fatal cases, necropsy with histopathology is essential for confirmation. Endoscopy may be useful in larger reptiles to visualize colonic lesions and obtain biopsies.

Hematology may reveal heterophilia (in reptiles, heterophils are the equivalent of neutrophils), monocytosis, and toxic changes in heterophils. Anemia may be present due to chronic blood loss. Serum biochemistry often shows elevated aspartate aminotransferase (AST) and bile acids if hepatic involvement is present. Hyperglobulinemia may occur due to chronic inflammation. In reptiles, uric acid is the primary nitrogenous waste product, and levels may be elevated with dehydration or renal impairment. Fecal analysis: direct smears may show motile trophozoites with characteristic pseudopodia; iodine-stained smears reveal cysts with up to four nuclei. PCR on feces or tissue is the most sensitive diagnostic test. Serology (ELISA) is available but less commonly used in clinical practice. In cases of hepatic abscess, cytology of aspirated material may show trophozoites and necrotic debris.

Radiography: Coelomic radiographs may reveal hepatomegaly, loss of serosal detail, or gas-filled bowel loops. In chelonians, radiographs are less useful due to the shell, but can still show hepatomegaly. Ultrasonography: Coelomic ultrasound is valuable for evaluating liver size and echotexture, detecting abscesses (hypoechoic to hyperechoic areas with fluid-filled centers), and guiding aspiration. Echocardiography may be performed if cardiac involvement is suspected. CT and MRI: Advanced imaging (CT or MRI) provides detailed assessment of hepatic lesions and can detect disseminated disease. CT is particularly useful in chelonians. Endoscopy: Rigid or flexible endoscopy can be used to visualize the colonic mucosa, identify ulcerations, and obtain biopsies for histopathology and PCR.

Cytology: Fine-needle aspiration of hepatic abscesses may yield necrotic debris, inflammatory cells (heterophils, macrophages), and trophozoites. Trophozoites are 15-30 μm in diameter, have a single nucleus with a central karyosome, and may contain ingested red blood cells. Histopathology: Intestinal lesions show ulcerative colitis with mucosal necrosis, hemorrhage, and infiltration of heterophils and macrophages. Trophozoites can be identified in the mucosa and submucosa. Hepatic lesions are characterized by multiple abscesses with central necrosis, surrounded by a granulomatous inflammatory reaction. Trophozoites are often present at the periphery of the abscesses. Special stains, such as periodic acid-Schiff (PAS) or immunohistochemistry, can aid in identification.

Treatment should be initiated promptly and includes supportive care and antiprotozoal therapy. Supportive care: Correct dehydration with fluid therapy (e.g., lactated Ringer's solution at 20-30 ml/kg SC or IO, adjusted based on species). Provide nutritional support via assisted feeding (e.g., carnivore critical care formula for snakes and lizards, herbivore formula for chelonians). Maintain optimal environmental temperature and humidity. Antiprotozoal therapy: Metronidazole is the drug of choice, administered at 25-50 mg/kg PO q24h for 10-14 days (snakes and lizards) or 20-40 mg/kg PO q24h for 10-14 days (chelonians). Alternatively, tinidazole at 50 mg/kg PO q24h for 5 days. In severe cases, combination therapy with paromomycin (100 mg/kg PO q24h for 7 days) may be considered. Antibiotics: Secondary bacterial infections should be treated with broad-spectrum antibiotics such as ceftazidime (20 mg/kg IM q72h) or enrofloxacin (5-10 mg/kg IM or PO q24h). Surgical intervention: Drainage of hepatic abscesses may be necessary in cases of large abscesses. Husbandry corrections: Thoroughly clean and disinfect the enclosure, remove fecal contamination, and quarantine affected animals.

The prognosis is guarded to poor in severe cases, especially in highly susceptible species like snakes. Early diagnosis and aggressive treatment improve the chances of recovery. Negative prognostic indicators include severe dehydration, hepatic involvement, neurological signs, and concurrent infections. In chelonians, which are often asymptomatic carriers, the prognosis is generally good with treatment. Chronic carriers may remain infected and serve as a source of infection for other animals. With appropriate therapy and husbandry improvements, many reptiles can recover, but long-term monitoring is essential to detect recurrence.

Follow-up should include serial fecal examinations (at least 3 negative samples, 1 week apart) to confirm clearance of the parasite. Repeat blood work (CBC, biochemistry) 2-4 weeks after treatment to assess organ function and resolution of inflammation. If hepatic abscesses were present, repeat ultrasound 4-6 weeks after treatment to monitor resolution. Re-check body weight weekly during recovery. Long-term husbandry audits should be performed to ensure proper sanitation, quarantine protocols, and stress reduction. Annual fecal screening is recommended for collections with a history of amebiasis.

Pearls: In snakes, the preferred venipuncture site is the ventral tail vein (coccygeal vein) using a 25-gauge needle. For lizards, the ventral abdominal vein or tail vein can be used. In chelonians, the jugular vein or subcarapacial sinus is accessible. Always use fresh feces for direct smears, as trophozoites are fragile and lyse quickly. PCR is highly sensitive and can detect low-level infections. Pitfalls: Avoid using corticosteroids in reptiles with amebiasis, as they can exacerbate the infection. Metronidazole can cause neurological signs at high doses; use the lower end of the dosage range. Do not rely solely on fecal flotation, as cysts may not float well; use direct smears and sedimentation techniques. Ensure proper disinfection of enclosures with agents effective against cysts, such as 10% ammonia or 1% sodium hypochlorite.

Based on Carpenter's Exotic Animal Formulary (6th edition): Metronidazole: Snakes and lizards: 25-50 mg/kg PO q24h for 10-14 days; Chelonians: 20-40 mg/kg PO q24h for 10-14 days. Tinidazole: 50 mg/kg PO q24h for 5 days (all reptiles). Paromomycin: 100 mg/kg PO q24h for 7 days (may be used in combination with metronidazole). Ceftazidime: 20 mg/kg IM q72h (for secondary bacterial infections). Enrofloxacin: 5-10 mg/kg IM or PO q24h (for secondary bacterial infections). Fluid therapy: Lactated Ringer's solution at 20-30 ml/kg SC or IO, adjusted based on hydration status. Nutritional support: Carnivore critical care formula (e.g., Oxbow Critical Care) for snakes and lizards; herbivore formula for chelonians, administered via gavage at 10-20 ml/kg q24-48h.

Key studies have demonstrated the efficacy of metronidazole in treating amebiasis in reptiles, with a success rate of over 90% in early cases. A study by Jacobson et al. (1983) reported that metronidazole at 50 mg/kg PO q24h for 10 days was effective in eliminating Entamoeba invadens in snakes. More recent research has evaluated the use of tinidazole and paromomycin as alternatives. PCR-based diagnostics have been validated for detection of E. invadens in fecal samples, with high sensitivity and specificity (e.g., a study by Stacy et al., 2015). Consensus guidelines from the Association of Reptilian and Amphibian Veterinarians (ARAV) recommend quarantine of new reptiles for at least 90 days, with fecal screening for parasites. The importance of environmental hygiene and stress reduction is emphasized in multiple reviews. Further research is needed on the efficacy of newer antiprotozoal agents and the development of vaccines.